Cytek Biosciences, Inc. financial data

Symbol
CTKB on Nasdaq
Industry
Laboratory Analytical Instruments
Location
47215 Lakeview Boulevard, Fremont, CA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 6, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 712 % -18.3%
Quick Ratio 104 % -10%
Debt-to-equity 25.1 % +12%
Return On Equity -1.39 % -116%
Return On Assets -1.13 % -106%
Operating Margin -13.1 % +90.4%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 132M shares -3.56%
Common Stock, Shares, Outstanding 132M shares -3.55%
Entity Public Float 1.03B USD
Common Stock, Value, Issued 132K USD -2.94%
Weighted Average Number of Shares Outstanding, Basic 131M shares -3.3%
Weighted Average Number of Shares Outstanding, Diluted 131M shares -3.3%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 198M USD +1262%
Revenue from Contract with Customer, Excluding Assessed Tax 198M USD +12.6%
Research and Development Expense 41.8M USD +3.29%
Selling and Marketing Expense 48.4M USD +11.8%
General and Administrative Expense 44.2M USD +6.72%
Operating Income (Loss) -25.8M USD -30.1%
Nonoperating Income (Expense) 9.56M USD -6%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -16.3M USD -68.1%
Income Tax Expense (Benefit) 1.3M USD
Net Income (Loss) Attributable to Parent -5.85M USD -125%
Earnings Per Share, Basic 0.02 USD/shares
Earnings Per Share, Diluted 0.02 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 178M USD +35.2%
Accounts Receivable, after Allowance for Credit Loss, Current 44.6M USD -10%
Inventory, Net 50.1M USD -23.8%
Other Assets, Current 1.91M USD -9.4%
Assets, Current 384M USD -9.59%
Property, Plant and Equipment, Net 18.1M USD +16.2%
Operating Lease, Right-of-Use Asset 9.33M USD -24.9%
Intangible Assets, Net (Excluding Goodwill) 21.4M USD -9.56%
Goodwill 16.2M USD -15.5%
Other Assets, Noncurrent 4.92M USD +63.5%
Assets 484M USD -7.87%
Accrued Liabilities, Current 15.5M USD -20.9%
Contract with Customer, Liability, Current 38M USD +3.73%
Liabilities, Current 52.4M USD -2.26%
Operating Lease, Liability, Noncurrent 8.11M USD -25.1%
Other Liabilities, Noncurrent 1.8M USD -12.1%
Liabilities 94.6M USD -6.22%
Accumulated Other Comprehensive Income (Loss), Net of Tax -195K USD +88.9%
Retained Earnings (Accumulated Deficit) -45.8M USD -62.2%
Stockholders' Equity Attributable to Parent 389M USD -8.26%
Liabilities and Equity 484M USD -7.87%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 3.96M USD +38.5%
Net Cash Provided by (Used in) Financing Activities 1.61M USD
Net Cash Provided by (Used in) Investing Activities -5.75M USD +96.6%
Common Stock, Shares Authorized 1B shares 0%
Common Stock, Shares, Issued 132M shares -3.55%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 1.51M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 178M USD +35.3%
Deferred Tax Assets, Valuation Allowance 2.27M USD +81.7%
Deferred Tax Assets, Gross 36M USD +39.7%
Operating Lease, Liability 10.5M USD -23.6%
Depreciation 3.4M USD +61.9%
Payments to Acquire Property, Plant, and Equipment 567K USD +12.3%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -16M USD -104%
Lessee, Operating Lease, Liability, to be Paid 11.1M USD -24.3%
Property, Plant and Equipment, Gross 25.1M USD +26.8%
Operating Lease, Liability, Current 2.41M USD -18.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.5M USD -18.4%
Lessee, Operating Lease, Liability, to be Paid, Year One 2.55M USD +52.7%
Operating Lease, Weighted Average Discount Rate, Percent 0.03 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 606K USD -34.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.32M USD -13.3%
Deferred Tax Assets, Operating Loss Carryforwards 1.41M USD +87.3%
Unrecognized Tax Benefits 3.64M USD +62.6%
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.05M USD -20.5%
Additional Paid in Capital 435M USD -4.2%
Amortization of Intangible Assets 3.6M USD +167%
Depreciation, Depletion and Amortization 1.7M USD +69.7%
Deferred Tax Assets, Net of Valuation Allowance 33.7M USD +37.5%
Share-based Payment Arrangement, Expense 24.2M USD +24.6%
Interest Expense 1.84M USD -30.8%